Infectious complications of lung cancer

ONCOLOGY

Volumn 19, Issue 2, 2005, Pages 185-194

  Seo, Susan K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CASPOFUNGIN; CEFACLOR; CEFUROXIME AXETIL; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FAMCICLOVIR; FLUCONAZOLE; GEMCITABINE; IFOSFAMIDE; INFLUENZA VACCINE; IRINOTECAN; ITRACONAZOLE; NAVELBINE; NYSTATIN; PACLITAXEL; PYRROLE DERIVATIVE; UNINDEXED DRUG; VALACICLOVIR; VINCRISTINE;

ADVANCED CANCER; ALOPECIA; ASPIRATION PNEUMONIA; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CHRONIC BRONCHITIS; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COST BENEFIT ANALYSIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; ELECTROLYTE DISTURBANCE; EMPHYSEMA; ESOPHAGITIS; ESOPHAGUS CANDIDIASIS; FEVER; HEARING LOSS; HERPES ZOSTER; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INFLUENZA; LABORATORY TEST; LOWER RESPIRATORY TRACT INFECTION; LUNG ABSCESS; LUNG INFECTION; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SURGERY; LUNG TUBERCULOSIS; MEDICAL DOCUMENTATION; MORBIDITY; MORTALITY; MOUTH INJURY; NAUSEA; NEPHROTOXICITY; NEUROPATHY; NEUTROPENIA; PATIENT CARE; REVIEW; SUSTAINED RELEASE PREPARATION; THORAX RADIOGRAPHY; THRUSH; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING; WOUND INFECTION; IMMUNE SYSTEM; INFECTION; LUNG TUMOR; MICROBIOLOGY; MULTIMODALITY CANCER THERAPY; RADIATION INJURY;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNE SYSTEM; IMMUNOCOMPROMISED HOST; INCIDENCE; INFECTION; LUNG NEOPLASMS; RADIATION INJURIES;

EID: 19444373147     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Feld R, Ginsberg RJ, Payne DG, et al: Lung, in Abeloff MD, Armitage JO, Lichter AS, et al (eds): Clinical Oncology, 2nd ed, pp 1398-1477. New York, Churchill Livingstone, 2000.
2. American Lung Association: Trends in lung cancer morbidity and mortality. Available at: http://www.lungusa.org/atf/cf/{7A8D42C2-FCCA-4604-8ADE- 7F5D5E762256}/lc1.pdf. Accessed on November 11, 2004.
3. Perlin E, Bang KM, Shah A, et al: The impact of pulmonary infections on the survival of lung cancer patients. Cancer 66:593-596, 1990.
4. Greene JN: Catheter-related complications of cancer therapy. Infect Dis Clin North Am 10:255-295, 1996.
5. Dale DC, Petersdorf RG: Corticosteroids and infectious diseases. Med Clin North Am 57:1277-1287, 1973.
6. Phair JP, Riesing KS, Metzger E: Bacteremic infection and malnutrition in patients with solid tumors: Investigation of host defense mechanisms. Cancer 45:2702-2706, 1980.
7. Putinati S, Trevisani L, Gualandi M, et al: Pulmonary infections in lung cancer patients at diagnosis. Lung Cancer 11:243-249, 1994.
8. Kohno S, Koga H, Oka M, et al: The pattern of respiratory infection in patients with lung cancer. Tohoku J Exp Med 173:405-411, 1994.
9. Berghmans T, Sculier JP, Klastersky J: A prospective study of infections in lung cancer patients admitted to the hospital. Chest 124:114-120, 2003.
10. Fuks JZ, Patel H, Hornedo J, et al: Infections in patients with non-small-cell lung cancer treated with intensive induction chemotherapy. Med Pediatr Oncol 14:255-261, 1986.
11. Gridelli C, Rossi A, Maione P: Treatment of non-small-cell lung cancer: State of the art and development of new biologic agents. Oncogene 22:6629-6638, 2003.
12. Spira A, Ettinger DS: Multidisciplinary management of lung cancer. N Engl J Med 350:379-392, 2004.
13. Stupp R, Monnerat C, Turrisi AT 3rd, et al: Small cell lung cancer: State of the art and future perspectives. Lung Cancer 45:105-117, 2004.
14. Stephan F, Boucheseiche S, Hollande J, et al: Pulmonary complications following lung resection: A comprehensive analysis of incidence and possible risk factors. Chest 118:1263-1270, 2000.
15. Patel RL, Townsend ER, Fountain SW: Elective pneumonectomy: factors associated with morbidity and operative mortality. Ann Thorac Surg 54:84-88, 1992.
16. Busch E, Verazin G, Antkowiak JG, et al: Pulmonary complications in patients undergoing thoracotomy for lung carcinoma. Chest 105:760-766, 1994.
17. Deslauriers J, Ginsberg RJ, Piantadosi S, et al: Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest 106:329S-330S, 1994.
18. Feld R: Complications in the treatment of small cell carcinoma of the lung. Cancer Treat Rev 8:5-25, 1981.
19. Hughes WT, Armstrong D, Bodey GP, et al: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730-751, 2002.
20. Werner-Wasik M, Yu X, Marks LB, et al: Normal-tissue toxicities of thoracic radiation therapy: Esophagus, lung, and spinal cord as organs at risk. Hematol Oncol Clin North Am 18:131-160, x-xi, 2004.
21. Khan SA, Wingard JR: Infection and mucosal injury in cancer treatment. J Natl Cancer Inst Monogr 29:31-36, 2001.
22. Vazquez JA, Sobel JD: Mucosal candidiasis. Infect Dis Clin North Am 16:793-820, 2002.
23. Phillips P, De Beule K, Frechette G, et al: A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS. Clin Infect Dis 26:1368-1373, 1998.
24. Rex JH, Walsh TJ, Sobel JD, et al: Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 30:662-678, 2000.
25. Villanueva A, Gotuzzo E, Arathoon EG, et al: A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. Am J Med 113:294-299, 2002.
26. Sarai R: Oral complications of cancer therapies. Management of acute viral infections. NCI Monogr 9:107-110, 1990.
27. Smith TF, Wold AD, Espy MJ, et al: New developments in the diagnosis of viral diseases. Infect Dis Clin North Am 7:183-201, 1993.
28. Gnann JW Jr, Whitley RJ: Clinical practice. Herpes zoster. N Engl J Med 347:340-346, 2002.
29. Huberman M, Fossieck BE Jr, Bunn PA Jr, et al: Herpes zoster and small cell bronchogenic carcinoma. Am J Med 68:214-218, 1980.
30. Feld R, Evans WK, DeBoer G: Herpes zoster in patients with small-cell carcinoma of the lung receiving combined modality treatment. Ann Intern Med 93:282-283, 1980.
31. Sethi S: Infectious exacerbations of chronic bronchitis: diagnosis and management. J Antimicrob Chemother 43(suppl A):97-105, 1999.
32. Wilson R: The role of infection in COPD. Chest 113:242S-248S, 1998.
33. Bartlett JG, Dowell SF, Mandell LA, et al: Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 31:347-382, 2000.
34. Shelhamer JH, Toews GB, Masur H, et al: NIH conference. Respiratory disease in the immunosuppressed patient. Ann Intern Med 117:415-431, 1992.
35. White P: Evaluation of pulmonary infiltrates in critically ill patients with cancer and marrow transplant. Crit Care Clin 17:647-670, 2001.
36. Dichter JR, Levine SJ, Shelhamer JH: Approach to the immunocompromised host with pulmonary symptoms. Hematol Oncol Clin North Am 7:887-912, 1993.
37. Collin BA, Ramphal R: Pneumonia in the compromised host including cancer patients and transplant patients. Infect Dis Clin North Am 12:781-805, 1998.
38. White DA, Wong PW, Downey R: The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med 161:723-729, 2000.
39. Liaw YS, Yang PC, Wu ZG, et al: The bacteriology of obstructive pneumonitis. A prospective study using ultrasound-guided transthoracic needle aspiration. Am J Respir Crit Care Med 49:1648-1653, 1994.
40. Rolston KV: The spectrum of pulmonary infections in cancer patients. Curr Opin Oncol 13:218-223, 2001.
41. Filaire M, Mom T, Laurent S, et al: Vocal cord dysfunction after left lung resection for cancer. Eur J Cardiothorac Surg 20:705-711, 2001.
42. Marik PE: Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 344:665-671, 2001.
43. Stewart CE, Winer-Muram HT, Jennings SG, et al: Necrotic mass-like upper lobe opacity. Chest 123:277-279, 2003.
44. Liao WY, Liaw YS, Wang HC, et al: Bacteriology of infected cavitating lung tumor. Am J Respir Crit Care Med 161:1750-1753, 2000.
45. Remiszewski P, Slodkowska J, Wiatr E, et al: Fatal infection in patients treated for small cell lung cancer in the Institute of Tuberculosis and Chest Diseases in the years 1980-1994. Lung Cancer 31:101-110, 2001.
46. Herbrecht R, Denning DW, Patterson TF, et al: Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408-415, 2002.
47. Groll AH, Walsh TJ: Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections. Expert Opin Investig Drugs 10:1545-1558, 2001.
48. Wilkin A, Feinberg J: Pneumocystis carinii pneumonia: A clinical review. Am Fam Physician 60:1699-1708, 1713-1714, 1999.
49. Chen YM, Chao JY, Tsai CM, et al: Shortened survival of lung cancer patients initially presenting with pulmonary tuberculosis. Jpn J Clin Oncol 26:322-327, 1996.
50. Tamura A, Hebisawa A, Tanaka G, et al: [Active pulmonary tuberculosis in patients with lung cancer]. Kekkaku 74:797-802, 1999.
51. Nagata N, Nikaido Y, Kido M, et al: Terminal pulmonary infections in patients with lung cancer. Chest 103:1739-1742, 1993.